Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023) Xue Bai , Ahmed Shaheen , Charlotte Grieco , Paolo D. Arienzo , Florentia Mina , Juliane A. Czapla , Aleigha R. Lawless , Eleonora Bongiovanni , Umberto Santaniello , Helena Zappi , Dominika Dulak , Andrew Williamson , Rebecca Lee , Avinash Gupta , Caili Li , Lu Si , Martina Ubaldi , Naoya Yamazaki , Dai Ogata , Rebecca Johnson , Benjamin C. Park , Seungyeon Jung , Gabriele Madonna , Juliane Hochherz , Yoshiyasu Umeda , Yasuhiro Nakamura , Christoffer Gebhardt , Lucia Festino , Mariaelena Capone , Paolo Antonio Ascierto , Douglas B. Johnson , Serigne N. Lo , Georgina V. Long , Alexander M. Menzies , Kenjiro Namikawa , Mario Mandala , Jun Guo , Paul Lorigan , Yana G. Najjar , Andrew Haydon , Pietro Quaglino , Genevieve M. Boland , Ryan J. Sullivan , Andrew J. S. Furness , Ruth Plummer , Keith T. Flaherty ECLINICALMEDICINE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
